Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Noncanonical function of an autophagy protein prevents spontaneous Alzheimer’s disease

Open access

Abstract

Mice with mutant ATG16L develop spontaneous, severe Alzheimer’s-like disease with age, despite normal autophagy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.abb9036

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Aged mice lacking the WD domain of Atg16L have robust Aβ deposition. All mice analyzed at 2 years of age, unless otherwise noted. (A) Representative immunofluorescence imaging of hippocampal Aβ. (B) Quantification of Aβ mean fluorescent intensity (MFI) in the hippocampus; each point represents an individual mouse. (C) High-resolution representative imaging of both extracellular and intraneuronal Aβ deposits in hippocampus. (D) Immunoblot analysis of whole-brain lysates for soluble and insoluble Aβ, C99 fragment using the MOAB-2 antibody and specific analysis of Aβ neurotoxic peptides 1 to 40 and 1 to 42. DAPI, 4′,6-diamidino-2-phenylindole. ****P < 0.0001.
Fig. 1 Aged mice lacking the WD domain of Atg16L have robust Aβ deposition. All mice analyzed at 2 years of age, unless otherwise noted. (A) Representative immunofluorescence imaging of hippocampal Aβ. (B) Quantification of Aβ mean fluorescent intensity (MFI) in the hippocampus; each point represents an individual mouse. (C) High-resolution representative imaging of both extracellular and intraneuronal Aβ deposits in hippocampus. (D) Immunoblot analysis of whole-brain lysates for soluble and insoluble Aβ, C99 fragment using the MOAB-2 antibody and specific analysis of Aβ neurotoxic peptides 1 to 40 and 1 to 42. DAPI, 4′,6-diamidino-2-phenylindole. ****P < 0.0001.CC BY-NC · PubMed Central
Fig. 2 Aged mice lacking the WD domain of Atg16L have robust Tau hyperphosphorylation. (A) Representative imaging of S199/202 Tau phosphorylation in hippocampus. (B) Quantification of Tau phosphorylation in the hippocampus; each point represents and individual mouse. (C) CA3 field–specific imaging of S199/202 Tau phosphorylation. (D) Immunoblot analysis of whole brain for multiple species of phospho-Tau (pTau) compared to total-Tau. Actin was used as a loading control. ***P < 0.001.
Fig. 2 Aged mice lacking the WD domain of Atg16L have robust Tau hyperphosphorylation. (A) Representative imaging of S199/202 Tau phosphorylation in hippocampus. (B) Quantification of Tau phosphorylation in the hippocampus; each point represents and individual mouse. (C) CA3 field–specific imaging of S199/202 Tau phosphorylation. (D) Immunoblot analysis of whole brain for multiple species of phospho-Tau (pTau) compared to total-Tau. Actin was used as a loading control. ***P < 0.001.CC BY-NC · PubMed Central
Fig. 3 Atg16L WD domain deletion leads to impaired recycling of Aβ receptors and decreased Aβ uptake. (A) Representative image of receptor recycling for TREM2, CD36, and TLR4 in primary microglia of the indicated genotypes. (B) Quantification of receptor recycling depicted as fluorescent area/total cell number. n = 4 performed in triplicate. (C) Secondary Aβ uptake measured in primary microglial cells of the indicated genotype. n = 3 performed in triplicate. **P < 0.01 and ***P < 0.001.
Fig. 3 Atg16L WD domain deletion leads to impaired recycling of Aβ receptors and decreased Aβ uptake. (A) Representative image of receptor recycling for TREM2, CD36, and TLR4 in primary microglia of the indicated genotypes. (B) Quantification of receptor recycling depicted as fluorescent area/total cell number. n = 4 performed in triplicate. (C) Secondary Aβ uptake measured in primary microglial cells of the indicated genotype. n = 3 performed in triplicate. **P < 0.01 and ***P < 0.001.CC BY-NC · PubMed Central
Fig. 4 Atg16L WD domain deletion results in reactive microgliosis and neuroinflammation. All mice were analyzed at 2 years of age, unless otherwise noted. (A) Representative immunofluorescence imaging of hippocampal microglial activation, as measured by Iba1. (B) Quantification of Iba1 MFI in the hippocampus; each point represents an individual mouse. (C) Representative imaging of microglial activation by Iba1 in the cerebral cortex. (D) Quantification of Iba1 MFI in the cerebral cortex; each point represents an individual mouse. (E) Morphological analysis of microglia marked by Iba1. (F) Quantitative PCR (qPCR) analysis of inflammatory cytokine expression from isolated hippocampi; n = 5 performed in triplicate. ***P < 0.001, **P < 0.01, and *P < 0.05.
Fig. 4 Atg16L WD domain deletion results in reactive microgliosis and neuroinflammation. All mice were analyzed at 2 years of age, unless otherwise noted. (A) Representative immunofluorescence imaging of hippocampal microglial activation, as measured by Iba1. (B) Quantification of Iba1 MFI in the hippocampus; each point represents an individual mouse. (C) Representative imaging of microglial activation by Iba1 in the cerebral cortex. (D) Quantification of Iba1 MFI in the cerebral cortex; each point represents an individual mouse. (E) Morphological analysis of microglia marked by Iba1. (F) Quantitative PCR (qPCR) analysis of inflammatory cytokine expression from isolated hippocampi; n = 5 performed in triplicate. ***P < 0.001, **P < 0.01, and *P < 0.05.CC BY-NC · PubMed Central
Fig. 5 Mice lacking the WD domain of Atg16L have active neurodegeneration, impaired synaptic plasticity, and memory impairment. All mice were analyzed at 2 years, of age unless otherwise noted. (A) Representative immunofluorescence imaging of neuronal cleaved caspase 3 staining. (B) High-resolution imaging of hippocampal cleaved caspase 3 staining of neurons. (C) Quantification of cleaved caspase 3 MFIs in the hippocampus; each point represents an individual mouse. (D) Representative immunofluorescence of hippocampal TUNEL staining. (E) Hippocampal LTP is reduced in Atg16L WD domain–deficient mice. Normalized CA3-CA1 field excitatory postsynaptic potentials (fEPSPs) as a function of time before and after induction of LTP. (F) Sucrose preference as measured as a percentage compared to standard water. (G) Spontaneous alternation percentage, as measured by Y-maze analysis. Novel object (H) preference and (I) discrimination index, as measured by NOR analysis. ***P < 0.001 and ****P < 0.0001.
Fig. 5 Mice lacking the WD domain of Atg16L have active neurodegeneration, impaired synaptic plasticity, and memory impairment. All mice were analyzed at 2 years, of age unless otherwise noted. (A) Representative immunofluorescence imaging of neuronal cleaved caspase 3 staining. (B) High-resolution imaging of hippocampal cleaved caspase 3 staining of neurons. (C) Quantification of cleaved caspase 3 MFIs in the hippocampus; each point represents an individual mouse. (D) Representative immunofluorescence of hippocampal TUNEL staining. (E) Hippocampal LTP is reduced in Atg16L WD domain–deficient mice. Normalized CA3-CA1 field excitatory postsynaptic potentials (fEPSPs) as a function of time before and after induction of LTP. (F) Sucrose preference as measured as a percentage compared to standard water. (G) Spontaneous alternation percentage, as measured by Y-maze analysis. Novel object (H) preference and (I) discrimination index, as measured by NOR analysis. ***P < 0.001 and ****P < 0.0001.CC BY-NC · PubMed Central
Fig. 6 Therapeutic response following inhibition of neuroinflammation in Atg16L WD-deficient mice with established AD pathology. Mice were treated as control or with MCC950 for 8 weeks. (A) Representative imaging of microglial activation by the Iba1 expression in the hippocampus. (B) Immunoblot analysis of inflammasome inhibition following MCC950 treatment. (C) Representative imaging of S199/202 Tau phosphorylation in CA3 field of the hippocampus. (D) Representative imaging of hippocampal cell death by TUNEL. (E) Spontaneous alternation percentage, as measured by Y-maze analysis. (F) Novel object preference and discrimination index, as measured by NOR analysis. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. n.s., not significant.
Fig. 6 Therapeutic response following inhibition of neuroinflammation in Atg16L WD-deficient mice with established AD pathology. Mice were treated as control or with MCC950 for 8 weeks. (A) Representative imaging of microglial activation by the Iba1 expression in the hippocampus. (B) Immunoblot analysis of inflammasome inhibition following MCC950 treatment. (C) Representative imaging of S199/202 Tau phosphorylation in CA3 field of the hippocampus. (D) Representative imaging of hippocampal cell death by TUNEL. (E) Spontaneous alternation percentage, as measured by Y-maze analysis. (F) Novel object preference and discrimination index, as measured by NOR analysis. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. n.s., not significant.CC BY-NC · PubMed Central
Fig. 7 Down-regulation of LANDO machinery in human AD. (A) Identification and information on normal and patients with AD–derived samples used. (B) Representative immunofluorescence imaging showing Aβ deposition in normal versus AD samples to confirm disease state. (C) qPCR analysis of transcriptional regulators and components of the LANDO machinery from whole-brain RNA. (D) Immunoblot analysis of components comprising the LANDO or autophagy machinery in whole-brain lysates. (E) Quantification of protein expression. *P < 0.05 and **P < 0.01. Rbcn, Rubicon; A.U., arbitrary units.
Fig. 7 Down-regulation of LANDO machinery in human AD. (A) Identification and information on normal and patients with AD–derived samples used. (B) Representative immunofluorescence imaging showing Aβ deposition in normal versus AD samples to confirm disease state. (C) qPCR analysis of transcriptional regulators and components of the LANDO machinery from whole-brain RNA. (D) Immunoblot analysis of components comprising the LANDO or autophagy machinery in whole-brain lysates. (E) Quantification of protein expression. *P < 0.05 and **P < 0.01. Rbcn, Rubicon; A.U., arbitrary units.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 63 references

Cited by

See all 119

Metadata

Authors
Heckmann, B. L., Teubner, B. J. W., Boada-Romero, E., Tummers, B., Guy, C., Fitzgerald, P., Mayer, U., Carding, S., Zakharenko, S. S., Wileman, T., & Green, D. R.
Affiliations
  • St. Jude Children's Research Hospital (US)
  • School of Biological Sciences, University of East Anglia, Norwich, Norfolk, UK.
  • Quadram Institute (GB)
  • University of East Anglia (GB)
Corresponding author
  • Heckmann, Bradlee L.
  • Green, Douglas R.
Venue
Science Advances
Published
2020-08-14
Volume
6
Issue
33
Pages
eabb9036-eabb9036
ISSN
2375-2548 (ISSN-L)
OpenAlex
W3049071965
Cited by
114
References
63
Citations by year
2026: 10 · 2025: 19 · 2024: 23 · 2023: 26 · 2022: 19 · 2021: 16 · 2020: 1
FWCI
9.32
Type
journal article
Language
en
Open access
Locations
  • Science Advances (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • UEA Digital Repository (University of East Anglia) (acceptedVersion, cc-by-nc)
Funders
  • National Institutes of Health (DC012833)
  • National Institute of Mental Health (MH097742)
  • National Cancer Institute (CA231620, CA231423, R35231620)
  • National Institute of Allergy and Infectious Diseases (AI40646, AI138492)
  • Biotechnology and Biological Sciences Research Council (BB/R00904X/1, BB/R012490/1: BBS/E/F/000PR10353, BBS/E/F/000PR10355)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, WD domain, non-canonical autophagy, amyloid-beta, microglia, neuroinflammation, tau hyperphosphorylation, memory impairment, neurodegeneration, autophagy-deficient mice
MeSH terms
Alzheimer Disease, Animals, Autophagy, Disease Models, Animal, Humans, Amyloid beta-Peptides, tau Proteins, Microglia, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Noncanonical function of an autophagy protein prevents spontaneous Alzheimer’s disease. https://app.cochat.ai/papers/10.1126/sciadv.abb9036
The paper
Heckmann, B. L., Teubner, B. J. W., Boada-Romero, E., Tummers, B., Guy, C., Fitzgerald, P., Mayer, U., Carding, S., Zakharenko, S. S., Wileman, T., & Green, D. R. (2020). Noncanonical function of an autophagy protein prevents spontaneous Alzheimer’s disease. Science Advances. https://doi.org/10.1126/sciadv.abb9036

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.